Broadcast Retirement Network's Jeffrey Snyder discusses the state of investment in the life sciences with scientist and biotech expert, Andrew R. Snyder, PhD. Jeffrey Snyder, Broadcast Retirement ...

Anthropic in October last year iterated its Claude AI model to better cater to biopharma purposes. Sanofi, Novo Nordisk, ...

When broken down, the word "biotechnology" can be separated into two parts: bio, which means life, and technology, which is the application of scientific knowledge for useful purposes. Therefore, ...

Gilead Sciences has agreed to buy German clinical-stage biotechnology company Tubulis for up to $5 billion in a deal that bolsters the biopharmaceutical company’s oncology pipeline.

Imagine the perfect drink — a cocktail, coffee, or kombucha, perhaps. Whatever the concoction, it came together iteratively — one taste test, one tweak at a time. In much the same way, mixing ...

Returning for its fourth year, Bisnow’s International Life Sciences & Biotech Conference returns to San Diego in September 2026, bringing together global leaders across biotechnology, real estate, ...

Marc Cummings, president and CEO of Life Science Washington, speaking at a one-day forum focused on AI-driven biotech that was held in Seattle in October 2025. (Life Science Washington Photo) Seattle ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. PALO ALTO, Calif. — At an annual meeting usually focused on the industry’s future, ...

The life sciences industry is experiencing transformative shifts driven by technological innovation and urgent global health needs. AAA Biotech, a leading provider of premium research reagents, is ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...